National trends in per-capita medical expenditures among U.S. adults with diabetes, 2000–2022
Authors' conclusion
The economic burden of diabetes on the national health care system has been increasing, with spending changes varying by medical service category. Interventions to prevent diabetes and its complications may help mitigate this growing economic burden.
Study context
- Population
- U.S. adults aged ≥18 years with self-reported diabetes, Medical Expenditure Panel Survey, 2000–2022
- Outcome
- Per-capita medical expenditures, total and by component (outpatient, inpatient, ER visits, prescription drugs, other medical services)
- Follow-up
- 2000 to 2022
Methodological detailsnationally representative survey, joinpoint regression
- Nationally representative survey
- Joinpoint regression
Main finding
As reported in the abstract
Total per-capita expenditure
Total per-capita expenditure, 2000 (95% CI $8,736-$10,663)
$9,700
Total per-capita expenditure, 2022 (95% CI $15,049-$17,086)
$16,067
Increase in total per-capita expenditure, 2000–2022
66 %
Significant upward trend periods for total expenditure
2000-2004 and 2011-2018
Observational data: associations, not effects.
Further findings
Expenditure by component, change 2000–2022
%
- Prescription drugs increase
- 144
- Outpatient increase
- 96
- Emergency room (ER) increase
- 122
- Other medical services increase
- 135
- Inpatient decrease
- 28
- Prescription drugs' share of total expenditures, 2022 (largest)
- 39
- Accelerated increase in prescription drug spending after 2012
Original publication
National trends in per-capita medical expenditures among U.S. adults with diabetes, 2000–2022. Diabetes Res Clin Pract. Published 29 March 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →